Sleeping Tablets in South Africa: What to Know First
If you've been lying awake night after night, the idea of a sleeping tablet is understandable. When sleep feels completely out of reach, you want something that works — tonight. This article explains what sleeping tablets are, how they work, why they are a short-term tool rather than a long-term solution, and what a clinician actually considers before prescribing one. It is written to be honest and straightforward, not to frighten or to sell.
Key takeaways
- "Sleeping tablets" is a broad term covering several classes of medicine with different mechanisms, risk profiles, and appropriate uses.
- Sedative-hypnotic medicines (including z-drugs and some older classes) are short-term tools only — generally appropriate for less than 2–4 weeks. With longer use, tolerance and rebound insomnia are well-documented concerns.
- Z-drugs are not benzodiazepines — they are a distinct class — but they share some of the same risks with extended use.
- Cognitive behavioural therapy for insomnia (CBT-I) is the evidence-based first-line treatment recommended by international sleep medicine bodies (AASM, 2021; ESRS, 2023). It produces more durable results than medication alone.
- Slumbr does not sell prescription medicine directly. Any prescription is a careful clinical decision made after a consultation, and only where clinically appropriate.
- A free Sleep Pattern Assessment is a good starting point before any consultation.
What are sleeping tablets, exactly?
The phrase "sleeping tablets" covers a range of medicines that work in different ways. In clinical practice, they fall into a few broad categories:
Sedative-hypnotics are the class most people picture when they think of "sleeping tablets." This group includes medicines that act on the brain's calming systems to promote sleep onset or maintenance. Within this class, z-drugs — a modern group of sedative-hypnotics — are commonly prescribed. They are sometimes confused with benzodiazepines (an older class), but they are pharmacologically distinct. That said, with prolonged use, some risks overlap: tolerance can develop, rebound insomnia is possible when stopping, and dependence is a concern with long-term use.
Melatonin-based medicines work differently — they act on the body's circadian system rather than directly sedating. They are used for specific sleep pattern problems (such as delayed sleep phase or jet lag) rather than classic insomnia. They have a different risk profile and are not a substitute for sedative-hypnotics in all contexts.
Low-dose medicines from other classes (such as certain antidepressants or antihistamines) are sometimes used off-label for sleep support in particular clinical situations. These are not "sleeping tablets" in the conventional sense, but a clinician may consider them depending on the full picture.
Over-the-counter antihistamine-based sleep aids are available without a prescription in South Africa. They can produce drowsiness, but are not recommended for ongoing use and are generally not appropriate for chronic insomnia.
Why are sleeping tablets a short-term tool?
This is one of the most important things to understand — and clinicians are not always as clear about it as they should be.
For short-term use (generally less than 2–4 weeks), sedative-hypnotics can be a helpful bridge in specific situations: around an acute stressor, a bereavement, an unavoidable disruption to routine. Used carefully and briefly, they can interrupt a cycle of sleeplessness before it becomes entrenched.
The problem arises with ongoing use. Over time:
- Tolerance can develop — meaning the same dose produces less effect, and there is a temptation to increase it.
- Rebound insomnia is common when stopping — the nights after discontinuation can be worse than before starting, which makes it harder to stop and can reinforce the belief that the tablet is "necessary."
- Dependence — psychological and in some cases physiological — is a documented risk with chronic use of sedative-hypnotic medicines.
This is not a reason to feel ashamed if you have been using sleeping tablets for longer than intended. It happens, and it is understandable. It is, however, a reason to have an honest conversation with a clinician about a plan that addresses the underlying sleep problem rather than just managing the nights.
Why CBT-I is the recommended first step
Cognitive behavioural therapy for insomnia (CBT-I) is not a self-help platitude. It is a structured, evidence-based treatment programme — the first-line recommendation for chronic insomnia from both the American Academy of Sleep Medicine (AASM, 2021) and the European Sleep Research Society (ESRS, 2023). It addresses the thought patterns and behavioural habits that perpetuate insomnia, rather than suppressing symptoms night by night.
CBT-I typically includes techniques such as sleep restriction, stimulus control, cognitive restructuring, and relaxation training. Delivered by a trained clinician, it produces results that are durable — that is, they persist after the programme ends, unlike the effects of medication, which stop when the medicine stops.
For many people with chronic insomnia, CBT-I alone is sufficient. For some, a short course of medication may be considered alongside CBT-I during a transition period. This is a clinical judgement, not a standard recommendation for everyone.
Does Slumbr prescribe sleeping tablets?
Slumbr is a physician-led online sleep clinic. Prescription medicine — including any sedative-hypnotic — is only considered after a thorough consultation, where clinically appropriate. It is never the default, and it is never available to purchase directly.
A consultation involves a review of your sleep history, current symptoms, any other medical conditions or medicines, and a discussion of what you've already tried. The goal is to understand your insomnia fully before deciding on any treatment direction.
Slumbr does not provide repeat prescriptions without ongoing clinical review, and we do not prescribe sedative-hypnotics for long-term use.
What about "natural" sleep products?
A range of supplements and over-the-counter products marketed for sleep are available in South Africa. Some contain ingredients that may support healthy sleep — but they are not a substitute for addressing the underlying drivers of chronic insomnia, and their evidence base varies. If you are considering a supplement, a clinician can help you evaluate whether it is appropriate for your situation.
Slumbr's supplement range — where it exists — is designed to support healthy sleep as part of a broader approach, not as a replacement for clinical assessment or treatment.
Is it safe to stop sleeping tablets on my own?
If you have been using sedative-hypnotics regularly, stopping abruptly is not recommended without medical guidance. Rebound insomnia and, in some cases, more serious withdrawal effects are possible. A clinician can help you taper safely and work on the underlying sleep problem at the same time.
This is a common, non-judgemental situation to bring to a consultation. You will not be criticised for how you got here.
Slumbr does not provide emergency care. If you are in crisis or experiencing thoughts of self-harm, please contact SADAG on 0800 567 567 (24/7 free) or go to your nearest emergency unit.
Frequently asked questions
Can I get sleeping tablets online in South Africa? Prescription medicine — including sedative-hypnotics — requires a valid prescription from a licensed clinician. Online clinics like Slumbr can issue prescriptions following a consultation, but not without one. Anyone offering prescription sleeping tablets without a consultation is operating outside South African regulatory requirements.
Are z-drugs safer than benzodiazepines? Z-drugs are a distinct class from benzodiazepines — they work via a related but different mechanism and were developed partly to address some of the risks of older benzodiazepines. In clinical practice, they are often described as having a somewhat different risk profile, particularly with short-term use. However, the evidence base shows that with prolonged use, many of the same concerns apply: tolerance, rebound insomnia, and dependence risk (NICE Technology Appraisal TA77; Victorri-Vigneau et al., 2019, Int J Neuropsychopharmacol). The prescribing guidance from NICE and the EMA for both classes emphasises short-term use only — generally not exceeding four weeks, including any tapering period. Regarding SA-specific scheduling, prescribing guidance follows SAHPRA product registrations for each individual agent; consult the relevant package insert and current SAHPRA schedule before prescribing.
What if I've been taking sleeping tablets for years? This is more common than you might think. Long-term use of sedative-hypnotics is associated with ongoing tolerance and an increased difficulty stopping. The right approach is a gradual, medically supervised taper combined with CBT-I to address the underlying insomnia — not abrupt discontinuation. A consultation is the right starting point.
How do I know if I need a consultation or just a sleep assessment? A free Sleep Pattern Assessment gives you a structured picture of your sleep and is a useful first step for most people. If you are already using prescription sleep medicine, or if your sleep has been significantly disrupted for an extended period, a consultation is the more appropriate starting point — it allows a clinician to review your full situation.
The right starting point
If you're considering sleeping tablets, the most useful first step is a clinical conversation — not an internet search or a pharmacy counter. A consultation with a sleep physician gives you an accurate picture of what's driving your insomnia and an honest plan for addressing it. That plan may or may not include medication, and if it does, it will also include a timeline and an exit strategy.
Not sure where to start? A free Sleep Pattern Assessment takes a few minutes and gives a clinician the context they need. It is an assessment tool — not a diagnosis.
Take the free Sleep Pattern Assessment →
Reviewed by a specialist physician.